GEM20110714: Final overall survival results of the phase III study of first-line gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma
KEY PUBLICATIONS OF NASOPHARYNGEAL CANCER
Chairpersons :
Manish Chandra, Radiation Oncologist, Mumbai DC Doval, Medical Oncologist, Delhi Bharat Parikh, Medical Oncologist, Ahmedabad
Speaker :
Atul Narayankar